Navigating DEA Quotas: Key To Psychedelics Industry Growth
A June 20 recommendation by a U.S. Drug Enforcement Administration judge advising the agency to proceed with its proposal to classify 2,5-Dimethoxy-4-iodoamphetamine, or DOI, into Schedule I brings a renewed urgency...To view the full article, register now.
Already a subscriber? Click here to view full article